Clinical Application of Blood Lactate, C-Reactive Protein, and the Age-Adjusted Charlson Comorbidity Index in Predictive Assessment of Malignant Risk of MRSA Pneumonia

Benzer Materyaller

• Charlson comorbidity index in predicting deaths in COVID-19 patients
  Yazar:: A. V. Svarovskaya, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-04-01)
• Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index
  Yazar:: Nicoletta Bernardini, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-12-01)
• The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
  Yazar:: Wang Z, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-07-01)
• The Charlson Comorbidity Index as a Predictor of mortality in hospitalized Covid-19 patients during the pandemic
  Yazar:: Moslem Taheri Soodejani, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-06-01)
• Application of Charlson Comorbidity Index to assess prognosis of 18-month mortality in patients with acute myocardial infarction
  Yazar:: T. H. Hoang, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-07-01)